RINGER LACTATE FRESENIUS KABI FRANCE, solution pour perfusion

solution pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution pour perfusion

Routeintraveineuse

Ingredient entries6

CountryFrance

Product identity

At a glance

Authorisation holder: FRESENIUS KABI FRANCE
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 66148284

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for RINGER LACTATE FRESENIUS KABI FRANCE, solution pour perfusion
Ingredient	Strength / reference	Source role
POTASSIUM (CHLORURE DE)solution	0,040 g100 ml	SAGroup 2
CALCIUM (CHLORURE DE) DIHYDRATÉsolution	0,027 g100 ml	SAGroup 3
SODIUM (CHLORURE DE)solution	0,600 g100 ml	SAGroup 1
LACTATE DE SODIUM, SOLUTION DEsolution	0,634 g100 ml	SAGroup 4
CHLORURE DE CALCIUM ANHYDREsolution	0,020 g100 ml	FTGroup 3
LACTATE DE SODIUM ANHYDREsolution	0,317 g100 ml	FTGroup 4

Pack references

Presentations (2)

10 flacon(s) polyéthylène de 500 ml

CIP13 3400938318425

Présentation active · Déclaration de commercialisation

10 flacon(s) polyéthylène de 1000 ml

CIP13 3400938318715

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 66148284 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →